Arcus Biosciences Reports First Quarter 2023 Financial Results and Provides a Pipeline Update

Go back to Arcus Biosciences Reports First Quarter 2023 Financial Results and Provides a Pipeline Update
(NYSE: RCUS) Delayed: 29.96 --0 (-0%)
Previous Close $29.96    52 Week High
Open $29.96    52 Week Low
Day High $29.96    P/E N/A 
Day Low $29.96    EPS
Volume 690